As of March 2024, the litigation involving over 20,000 plaintiffs in a California coordinated proceeding and several thousand in federal court against Gilead continues to progress. The focus of these lawsuits is on Gilead’s alleged deliberate delay in developing a safer version of the drug tenofovir disoproxil fumarate (TDF) for financial reasons, despite knowledge of…
Recent updates on Truvada lawsuits indicate ongoing litigation against Gilead as of February 2024. Plaintiffs are pursuing legal action not only concerning Truvada but also other drugs containing tenofovir disoproxil fumarate (TDF), alleging toxicity to bones and kidneys. Despite the absence of court-approved settlements or jury verdicts thus far, the litigation progresses, with the scheduling…
Truvada (emtricitabine and tenofovir disoproxil fumarate) has become the subject of lawsuits alleging adverse effects, including kidney problems and bone loss. Plaintiffs argue that Gilead, the drug’s manufacturer, withheld a potentially safer alternative, tenofovir alafenamide, to maximize profits from Truvada and other medications containing tenofovir disoproxil fumarate (TDF). Latest Truvada Lawsuit Updates: As of…